Benzimidazole derivatives: Spectrum of pharmacological activity and toxicological properties (a review)

Pharmaceutical Chemistry Journal

Volumn 33, Issue 5, 1999, Pages 232-243

  Spasov, A A ^a   Yozhitsa, I N ^a   Bugaeva, L I ^a   Anisimova, V A ^a  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001400315     PISSN: 0091150X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02510042     Document Type: Review

References (268)

1. F. Hobrecker, Ber. Dtsch. Chem. Ges., Berlin, 5, 920-924 (1872).
2. D. Hodgkin, J. Pickworth, S. Robertson, et al., Nature, 176(4477), 325-328 (1955).
3. J. Brown, D. Craig, and A. Kandel, Proc. Soc. Exp. Biol. Med., 83 (2), 408-411 (1953).
4. I. Tamm, K. Folkers, C. Shunk, et al., J. Exp. Med., 98(3), 245-259 (1953).
5. I. Tamm, M. Nemes, and S. Osterhout, J. Exp. Med., 111(3), 339-349 (1960).
6. I. Tamm, R. Bablanian, M. Nemes, et al., J. Exp. Med., 113(4), 625-655 (1961).
7. B. C. Bishop, E. T. Chelton, and A. I. Jones, Biochem. Pharmacol., 13(5), 571-574 (1964).
8. D. W. Woolley, J. Biol. Chem., 152(1), 225-232 (1944).
9. C. Hubschwerlen, P. Pflieger, J. L. Specklin, et al., J. Med. Chem., 35(8), 1385-1392 (1992).
10. J. Pernak, A. Skrzypezak, L. Michalak, et al., Arch. Pharm. (Weinheim, Ger.), 326(4), 237-240 (1993).
11. L. Mishra, V. K., Singh, N. K. Dubey, and A. K. Mishra, Biosci. Biotechnol. Biochem., 57(6), 989-991 (1993).
12. P. Hrelia, M. Morotti, F. Vigagni, et al., Mutagenesis, 8(3), 183-188 (1993).
13. M. Pedini, G. De Meo, A. Ricci, et al., Farmaco, 49(4), 303-304 (1994).
14. R. W. Buckheit, M. G. Hollingshead, J. G. Decker, et al. Antiviral. Res., 21(3), 247-265 (1993).
15. S. M. el Dareer, K. F. Tillery, L. M. Rose, et al., Drug Metab. Dispos., 21(2), 231-235 (1993).
16. P. L. Boyer, M. J. Currens, J. B. McMahon, et al., J. Virol., 67(4), 2412-2420 (1993).
17. D. P. Green, J. Reprod. Fertil., 96(2), 581-591 (1992).
18. A. Y. Chen, C. Yu, A. Bodley, et al., Cancer Res., 53(6), 1332-1337 (1993).
19. M. F. Brana, J. M. Castellano, G. Keilhauer, et al., Anticancer Drug Des., 9(6), 527-538 (1994).
20. A. Chimirri, S. Grasso, A. M. Montforte, et al., Farmaco, 49(5), 337-344 (1994).
21. S. B. Seredenin, Yu. G. Bobkov, A. D. Durnev, and O. Yu. Dubovskaya, Byull. Eksp. Biol. Med., 52(7), 76-79 (1986).
22. S. B. Seredenin and A. D. Durnev, Pharmacological Protection of Genome [in Russian], VINITI, Moscow (1992).
23. N. O. Daugel-Dauge, A. D. Durnev, A. V. Kulakova, et al., Vestn. Ross. Akad. Med. Nauk, 1, 29-38 (1995).
24. V. N. Zinov'eva, A. A. Spasov, O. V. Ostrovskii, et al., Vestn. Volgograd. Med. Akad., No. 4, 34-38 (1998).
25. A. P. Chavarria, J. C. Swartzwelder, V. M. Villarejos, et al., Am. J. Trop. Med. Hyg., 22, 592-595 (1973).
26. K. Maertens and M. Wery, Trans. Roy Soc. Trop. Med. Hyg., 69, 359-360 (1975).
27. S. K. K. Seah, Can. Med. Assoc. J., 115, 777-779 (1976).
28. T. C. Beard, M. D. Rickard, and H. T. Goodman, Med. J. Aust., 1, 633-635 (1978).
29. P. Kern, M. Dietrich, and K. J. Volkmer, Tropenmed Parasitol., 30, 65-72 (1979).
30. J. S. Keystone and J. K. Murdoch, Ann. Int. Med., 91, 582-586 (1979).
31. A. E. Frol'tseva, N. D. Lychko, and M. N. Lebedeva, Med. Parazitol. Parazitar. Bolezni, 3, 72-74 (1983).
32. W. H. Eyster, Jr., Arch Dermatol., 95, 620-621 (1967).
33. C. M. Davis and R. M. Israel, Arch. Dermatol., 97, 325-326 (1968).
34. P. S. E. G. Harland, R. H. Meakins, and R. H. Harland, Br. Med. J., 2, 772 (1977).
35. J. M. Goldsmid and E. H. Froese, Cent. Afr. J. Med., 23, 250-251 (1977).
36. E. B. Scowden, W. Schaffner, and W. J. Stone, Medicine (Baltimore), 57, 527-544 (1978).
37. S. C. Tolliver, E. T. Lyons, J. H. Drudge, et al., Am. J. Vet. Res., 54(6), 908-913 (1993).
38. E. T. Lyons, J. H. Drudge, S. C. Tolliver, et al., Vet. Parasitol., 52(3-4), 271-277 (1994).
39. D. N. Ali and D. R. Hennessy, Int. J. Parasitol., 25(1) 71-74 (1995).
40. H. T. Purvis, J. C. Whittier, S. L. Boyles, et al., J. Anim. Sci., 72(4), 817-823 (1994).
41. J. Landuyt, M. Debackere, J. Vercruysse, and Q. McKellar, J. Vet. Pharmacol. Ther., 18(3), 180-186 (1995).
42. J. J. Vermunt, D. M. West, and W. E. Pomroy, Vet. Rec., 137(2), 43-45 (1995).
43. J. Surin, Southeast Asian J. Trop. Med. Public Health, 26(1), 128-134 (1995).
44. I. A. Barger, J. W. Steel, and B. R. Rodden, Aust. Vet. J., 70(2), 41-48 (1993).
45. U. M. Morgan, J. A. Reynoldson, and R. C. Thompson, Antimicrob. Agents Chemother., 37(2), 328-331 (1993).
46. C. E. Lanusse, L. H. Gascon, and R. K. Prichard, J. Vet. Pharmacol. Ther., 18(3), 196-203 (1995).
47. A. W. Stitt, I. Fairweather, and R. O. Mackender, Int. J. Parasitol., 25(4), 421-429 (1995).
48. A. W. Carr, R. O. McCracken, and W. H. Stillwell, J. Parasitol., 79(2), 198-204 (1993).
49. S. N. Mahato, L. J. Harrison, and J. A. Hammond, Vet. Rec., 135(24), 579-580 (1994).
50. E. T. Lyons, J. H. Drudge, S. C. Tolliver, and S. Stamper, Am. J. Vet. Res., 54(3), 406-410 (1993).
51. S. R. Stoitsova and L. N. Gorchilova, J. Helminthol., 68(1), 73-80 (1994).
52. J. L. del Estal, M. L. A. Bujidos, R. B. Fouce, et al., J. Pharm. Biomed. Anal., 12(11), 1471-1474 (1994).
53. H. Q. Ying and X. F. Dai, Yao Hsueh. Hsueh. Pao, 28(7), 553-556 (1993).
54. E. Ravina, R. S. Alonso, J. Fueyo, et al., Arzneim. Forsch., 43(6), 689-694 (1993).
55. S. Watts, E. Rapson, A. Atrins, et al., Biochem. Pharmacol., 31, 3035 (1982).
56. B. A. Porai-Koshits, Sh. F. Ginzburg, and L. S. Éfros, Zh. Obshch. Khim., 17(10), 1768-1774 (1947).
57. E. N. Pavlova, O. N. Liberman, and S. V. Perova, in: Pharmacology of New Medicinal Preparations [in Russian], Nauka, Leningrad (1947), pp. 34-35.
58. N. N. Savitskii, in: Pharmacology of New Medicinal Preparations [in Russian], Nauka, Leningrad (1947), pp. 23-25.
59. N. A. Tolubeeva and S. A. Tseitlin, in: Pharmacology of New Medicinal Preparations [in Russian], Nauka, Leningrad (1947), pp. 36-38.
60. D. S. Paskov, Farmakol. Toksikol., 11(3), 18-22 (1948).
61. D. S. Paskov, Farmakol. Toksikol., 11(2), 20-26 (1948).
62. S. V. Anichkov, Novosti Med., 12, 1-21 (1949).
63. E. B. Derankova, Dibazole in the Prophylaxis and Treatment of Late Toxicosis in Pregnants [in Russian], Nauka, Leningrad (1961).
64. T. Ogihara, M. Nagano, H. Mikami, et al., Clin. Ther., 16(1), 74-86 (1994).
65. Proc. 15th Sci. Meet. Int. Soc. Hypertension, Satellite Symp. "Angiotensin II Receptor Antagonists: Can They Go Beyond ACE Inhibitors?" (Melbourne, Australia, March 1994), Blood Press, Melbourne (1994), Suppl. 5, pp. 1-133.
66. X. C. Li and R. E. Widdop, Hypertension, 26(6), 989-997 (1995).
67. E. Delacretaz, J. Nussberger, J. Biollaz, et al., Hypertension, 25(1), 14-21 (1995).
68. S. Kim, M. Kawamura, H. Wanibuchi, et al., Circulation, 92(1), 88-95 (1995).
69. G. Mehrke, X. G. Zong, V. Flockerzi, and F. Hofmann, J. Pharmacol. Exp. Ther., 271(3), 1483-1488 (1994).
70. R. S. Vander Heide, L. M. Schwartz, and K. A. Reimer, Cardiovasc. Res., 28(10), 1526-1532 (1994).
71. J. Su, N. Renaud, A. Carayon, et al., Br. J. Pharmacol., 113(2), 395-402 (1994).
72. A. Rutledge and D. J. Triggle, Eur. J. Pharmacol., 280(2), 155-158 (1995).
73. Y. Sato, H. Watanabe, and N. Himori, Nippon Yakurigaku Zasshi, 105(3), 171-176 (1995).
74. R. Gompper, Effenberger, Unbersnchunger in der Azolzeihe. XI. Synthese und Reaktionen der 2-Chloraxozole, Berlin (1959), Vol. 92, p. 1928.
75. G. V. Kovalev, A. A. Spasov, P. A. Bakumov, et al., Abstracts of Papers. All-Union Conf. "Synthesis, Pharmacology, and Clinical Aspects of New Psychotropic and Cardiovascular Agents" [in Russian], Volgograd (1989), pp. 127-128.
76. G. V. Kovalev, A. A. Spasov, A. M. Simonov, et al., Abstracts of Papers. The 3rd All-Union Symp. on the Targeted Search for New Physiologically Active Substances [in Russian], Riga (1979), p. 40.
77. A. M. Simonov, A. A. Belous, V. A. Anisimova, and S. V. Ivanovskaya, Khim.-Farm. Zh., 3(1), 7-10 (1969).
78. S. V. Ivanovskaya, Trudy Volgograd. Med. Inst., 21, 175-178 (1968).
79. S. V. Ivanovskaya, Cand. Sci. (Med.) Thesis [in Russian], Volgograd (1969).
80. G. V. Kovalev, S. M. Gofman, S. V. Ivanovskaya, et al., Farmakol. Toksikol., No. 3, 232-237 (1973).
81. G. V. Kovalev, S. V. Ivanovskaya, S. M. Gofman, and V. I. Petrov, Abstracts of Papers. The 4th Volga Region Conf. Physiologists with Participation of Biochemists, Pharmacists, and Morphologists [in Russian], Cheboksary (1973), Vol. 2, p. 34.
82. A. A. Spasov, Author's Abstract of Cand. Sci. (Med.) Thesis [in Russian], Moscow (1975).
83. A. A. Spasov, Trudy Volgograd. Med. Inst., 30(3), 99-104 (1977).
84. G. V. Kovalev, A. A. Spasov, V. I. Porotikov, and T. G. Kvachenkova, Abstracts of Papers. The 2nd All-Union Symp. "Blood Circulation under High-Altitude and Experimental Hypoxia [in Russian], Frunze (1982).
85. A. A. Spasov and T. G. Kvachenkova, Problems in Clinical and Experimental Medicine [in Russian], Volgograd. Med. Inst., Volgograd (1979), pp. 50-51.
86. G. V. Kovalev, A. A. Spasov, S. A. Nikitin, et al., USSR Inventor's Certificate No. 976,665; Byull. Izobret., No. 7, 13-14 (1978).
87. T. I. Panchenko, G. V. Kovalev, and A. A. Spasov, Abstracts of Papers. The 3rd All-Union Conf. on Bioantioxidants [in Russian], Moscow (1982), Vol. 2, pp. 142-143.
88. L. M. Gaevaya, Abstracts of Papers. The 3rd Int. Conf. "Ecologic Pathology and Its Pharmacological Correction (Chita, 26-27 June, 1991) [in Russian], Chita (1991), Part 2, p. 119.
89. D. McTavish, M. M. T. Buckley, and R. C. Heel, Drugs, 42, 138-170 (1991).
90. C. W. Howden, Clin. Pharmacokinet., 20, 38-49 (1991).
91. F. Massoomi, J. Savage, and C. J. Destache, Pharmacotherapy, 13, 46-59 (1993).
92. R. D. Shamburek and M. L. Schubert, Balilliere's Clin. Gastroenterol., 7, 23-54 (1993).
93. J. J. Kuiper, Am. J. Med., 95, 248 (1993).
94. W. A. Belli and J. Fryklund, Antimicrob. Agents. Chemother., 39(8), 1717-1720 (1995).
95. H. Bliesath, R. Huber, M. Hartmann, et al., Int. J. Clin. Pharmacol. Ther., 32(1), 44-50 (1994).
96. W. Schepp, M. Rehner, and L. Witzel, Aliment. Pharmacol. Ther., 8 (Suppl. 1), 53-57 (1994).
97. V. W. Steinijans, R. Huber, M. Hartmann, et al., Int. J. Clin. Pharmacol. Ther., 32(8), 385-399 (1994).
98. H. G. Dammann, T. Bethke, F. Burkhardt, et al., Aliment. Pharmacol. Ther., 8(5), 549-554 (1994).
99. L. Witzel, H. Gutz, W Huttemann, et al. Aliment. Pharmacol. Ther., 9(1), 19-24 (1995).
100. G. Sachs, J. M. Shin, C. Briving, et al., Ann. Rev. Pharmacol. Toxicol., 35, 277-305 (1995).
101. J. Mossner, A. H. Holscher, R. Herz, and A. Schneider, Aliment. Pharmacol. Ther., 9(3), 321-326 (1995).
102. G. T. Tucker, Aliment. Pharmacol. Ther., 8 (Suppl. 1), 33-38 (1994).
103. R. Arnold, Aliment. Pharmacol. Ther., 8 (Suppl. 1), 65-70 (1994).
104. T. Takimoto, K. Ido, Y. Taniguchi, et al., J. Clin. Gastroenterol., 20 (Suppl. 2), 121-124 (1995).
105. M. Masuda, A. Uchida, H. Matsukura, and T. Kamishiro, Nippon Yakurigaku Zasshi, 104(4), 325-335 (1994).
106. K. Ishihara, T. Ichikawa, Y. Komuro, et al., Arzneim. Forsch., 44(7), 827-830 (1994).
107. H. Matsukura, M. Masuda, A. Uchida, and T. Kamishiro, Nippon Yakurigaku Zasshi, 104(2), 91-100 (1994).
108. A. A. Spasov, Abstracts of Papers. The 1st All-Russia Conf. "Mankind and Drugs" (Moscow, 12-16 April, 1992) [in Russian], Moscow (1992), Vol. 2, p. 447.
109. Astemizole - Another Non-Sedating Antihistamine, Lett. Med. Drugs Ther., 31, 43-44 (1989).
110. Safety of Terfenadine and Astemizole, Med. Lett. Drugs Ther., 34, 9-10 (1992).
111. Treatment of Seasonal and Perennial Rhinitis, Br. J. Med., 283, 808-810 (1981).
112. T. G. Burke and A. H. Mutnick, Ann. Pharmacother, 27, 239-241 (1993).
113. Janssen Pharmaceutica, Hismanal (Astemizole): Prescribing Information, in: Physicians Desk Reference (47th Edition), Medical Economics Company Inc., Montvale, NJ (1993).
114. Janssen Pharmaceutica, Hismanal (Astemizole): Clinical Monograph, Piscataway, NJ (1991).
115. D. M. Richards, R. N. Brogden, T. M. Heel, et al., Drugs, 28, 38-61 (1984).
116. P. Danjou, P. Molinier, I. Berlin, et al., Br. J. Clin. Pharmacol., 34(4), 328-331 (1992).
117. E. F. Vuurman, M. M. Uiterwijk, P. Rosenzweig, et al., Eur. J. Clin. Pharmacol., 47(3), 253-259 (1994).
118. J. Levrier, D. Duval, M. Prouteau, et al., Arzneimit. Forsch., 45(5), 559-568 (1995).
119. J. Benavides, H. Schoemaker, C. Dana, et al., Arzneimit. Forsch., 45(5), 551-558 (1995).
120. A. Patat, M. C. Perault, B. Vandel, et al., Br. J. Clin. Pharmacol., 39(1), 31-38 (1995).
121. J. M. Yanni, D. J. Stephens, D. W. Parnell, et al., J. Ocul. Pharmacol., 10(4), 665-675 (1994).
122. N. A. Sharif, S. X. Su, and J. M. Yanni, J. Ocul. Pharmacol., 10(4), 653-664 (1994).
123. G. I. Elmer, J. O. Pieper, S. R. Goldberg, and F. R. George, Psychopharmacalogy (Berlin), 117(1), 23-31 (1995).
124. P. Hyyatia and J. D. Sinclair, Psychopharmacology (Berlin), 111(4), 409-414 (1993).
125. T. F. Burke, J. H. Woods, J. W. Lewis, and F. Medzihradsky, J. Pharmacol. Exp. Ther., 271(2), 715-721 (1994).
126. M. Sala, D. Braida, P. Calcaterra, et al., Eur J. Pharmacol., 217(1), 37-41 (1992).
127. T. Suzuki, F. R. George, and R. A. Meisch, Pharmacol. Biochem. Behav., 42(4), 579-586 (1992).
128. W. Kuzmierkiewiez, H. Fox, and E. Hac, Pharmazie, 40(4), 462-464 (1985).
129. K. Taniguchi, S. Shigenaga, et al., Chem. Pharm. Bull. Tokyo, 41(2), 301-309 (1993).
130. Merck, Sharpe, & Dohme, Mintezol: Prescribing Information, West Point, PA (1984).
131. J. D. Geratz, K. B. Pryzwansky, J. H. Schwab, et al., Am. J. Pathol., 142(4), 1227-1237 (1993).
132. S. C. Gilman, R. P. Carlson, J. Chang, et al., Agents Actions, 17(1), 53-59 (1986).
133. S. C. Gilman, R. P. Carlson, J. F. Daiels, et al., Int. J. Immunopharm., 9(1), 9-16 (1987).
134. G. V. Ershov, Abstracts of Papers. The 1st Interinstitution Scientific-Practical Conference of Students and Young Scientists of the Volgograd Region "Medicine, Public Health, Physical Culture, and Sports (Volgograd, 5-9 December, 1994) [in Russian], Volgograd. Med. Akad., Volgograd (1994), pp. 8-9.
135. L. I. Ratnikova, Zh. Mikrobiol., Epidemiol., Immunobiol., No. 9, 56-58 (1991).
136. L. I. Ratnikova, Klin. Med., 7, 89-91 (1991).
137. S. M. Gofman and S. M. Ermilova, Trudy Volgograd. Med. Inst., 30(3), 180-185 (1977).
138. V. F. Dolgushina, Zh. Mikrobiol., Epidemiol., Immunobiol., No. 4, 56-58 (1991).
139. L. I. Ratnikova, in: Problems in Epidemiology, Immunology, and Diagnostics of Viral Infections: A Republic Collection of Scientific Papers [in Russian], Research Institute of Viral Infections, Sverdlovsk (1990), pp. 82-85.
140. V. I. Putintsev, T. V. Sysoikina, and L. G. Kozyr', Correction of Immune Disorders in Patients with Prebronchitis Diagnosis by Antihypoxant Bemithyl [in Russian], Medical Institute, Lugansk (1993), p. 5.
141. P. E. Alashaev, Abstracts of Papers. Sci. Conf. Military Medical Academy [in Russia], Leningrad (1957), pp. 3-4.
142. B. A. Chirkov, Abstracts of Papers. Sci. Conf. Military Medical Academy [in Russia], Leningrad (1959), pp. 145-146.
143. B. A. Chirkov, Farmakol. Toksikol., 23(5), 455-458 (1960).
144. A. M. Kapitanenko, Abstracts of Papers. Sci. Conf. Military Medical Academy [in Russia], Leningrad (1957), pp. 46-47.
145. A. M. Kapitanenko, Vrachebn. Delo, 7, 713-714 (1958).
146. G. P. Dudchenko, A. A. Spasov, V. A. Anisimova, et al., in: Fundamental Investigations - a Basis for Drug Creation. Abstracts of Papers. The 1st Meet. All-Russia Sci. Soc. Pharmacists (Volgograd, 9-13 October, 1995) [in Russian], Moscow (1995).
147. A. A. Spasov, G. P. Dudchenko, A. F. Turchacva, et al., Vestn. Volgograd. Med. Akad., No. 1, 33-36 (1995).
148. T. B. Sibiryakova, A. F. Turchaeva, and É. V. Besedina, Current Problems in Medicine. Proc. 49th Sci. Session [in Russian], Volgograd (1995), pp. 79-80.
149. T. B. Sibiryakova, P. A. Bakumov, N. P. Larionov, and A. A. Spasov, Abstracts of Papers. All-Russia Sci. Conf. "Creation of Drugs" (Moscow, 26-30 October, 1996) [in Russian], Moscow (1996), pp. 171-172.
150. G. Rusu, G. Danila, and M. Nechifor, Rev. Med. Chir. Soc. Med. Nat. Iasi., 97(2), 269-271 (1993).
151. S. M. Yung, Thromb. Res., 23(4-5), 401-410 (1981).
152. T. M. Plotnikova, Z. V. Kulakova, and M. B. Plotnikov, Byull. Eksp. Biol. Med., 111(4), 386-388 (1991).
153. T. M. Plotnikova, N. N. Firsov, and O. E. Vaizova, Eksp. Klin. Farmakol., 55(4), 29-31 (1992).
154. O. E. Vaizova, T. M. Plotnikova, and M. B. Plotnikov, Eksp. Klin. Farmakol., 57(1), 25-27 (1994).
155. M. A. Rozin, Pharmacology of Pathological Processes [in Russian], Nauka, Leningrad (1951), pp. 269-290.
156. M. A. Rozin, Farmakol. Toksikol., 14(1), 21-22 (1951).
157. M. A. Rozin, Proc. Sci. Meet. on Experimental Study of and Clinical Testing of Dimezole [in Russian], Leningrad (1961), pp. 5-10.
158. M. A. Rozin, Protein Synthesis and Cell Resistance [in Russian], Nauka, Leningrad (1971), pp. 3-6.
159. N. V. Lazarev and M. A. Rozin, Sov. Med., 4, 24-26 (1951).
160. N. N. Anosov and M. A. Rozin, Proserine, Eserine, Dibazole, and Their Application in Neuropathology [in Russian], Nauka, Leningrad (1956).
161. Yu. Vu. Zil'bert, Proc. 7th. Sci. Conf. Naval Medical Academy [in Russia], Leningrad (1953), p. 190.
162. M. Ya. Mikhel'son and Ya. P. Savinskii, Farmakol. Toksikol., No. 3, 28 (1955).
163. J. M. Sigh, J. Med. Chem., 12, 962 (1969).
164. B. E. Maryanoff, W. Ho, D. McComsey, et al., J. Med. Chem., 38(1), 16-20 (1995).
165. M. N. Yarkova, Yu. A. Blednov, and S. B. Seredenin, Proc. Int. Conf. "Biological Basis of Individual Sensitivity to Psychotropic Drugs" (Moscow, 22-26 May, 1993), Moscow (1993), p. 151.
166. M. A. Yarkova, Yu. A. Blednov, and S. B. Seredenin, in: Actual Problems in Experimental and Clinical Pharmacology [in Russian], Smolensk Obl. Tipogr., Smolensk (1994), pp. 139-140.
167. S. B. Seredenin and M. A. Yarkova, RF Patent Application No. 94,022,663; Byul. Izobret., No. 6, 11-12 (1995).
168. E. I. Bakhareva, Author's Abstract of Doctoral (Biol. Sci.) Thesis [in Russian], Moscow (1995).
169. E. V. Avdeeva, Fundamental Investigations - a Basis for Drug Creation. Abstracts of Papers. The 1st Meet. All-Russia Sci. Soc. Pharmacists (Volgograd, 9-13 October, 1995) [in Russian], Moscow (1995), p. 7.
170. M. P. Martres, M. Baudry, and J. Ch. Schwartz, Life Sci., 23, 1781-1784 (1978).
171. B. Costall, D. H. Fortune, and R. J. Naylor, J. Pharm. Pharmacol., 31, 344-347 (1979).
172. Y. Agid, Rev. Neurol., 137(1), 49-51 (1981).
173. J. P. Bercovici, Nouv. Presse Med., 10(29), 2421-2425 (1981).
174. J. M. Van Nueten, C. Ennis, L. Helser, et al., Life Sci., 23(5), 453-457 (1978).
175. B. Cox and C. Ennis, Br. J. Pharmacol., 71, 177-184 (1980).
176. B. Costall, R. J. Naylor, and H. A. Sahyoun, Br. J. Pharmacol., 73, 312 (1981).
177. R. Gorich, T. R. Weihrauch, and H. Kilbinger, Arch. Pharmacol., 318, 308-312 (1982).
178. P. A. J. Janssen and F. T. N. Allewijn, Arzneim. Forsch., 19, 279-282 (1968).
179. P. A. J. Janssen, C. J. E. Niemegeers, K. H. L. Schellekens, et al., Arzneim. Forsch., 18, 261-279 (1968).
180. R. M. Pinder, R. N. Brogden, P. R. Sawyer, et al., Drugs, 12, 1-40 (1976).
181. McNeil Pharmaceutical, Orap (Pimozide) Tablets: Hospital formulary Information, Spring House, PA (1984).
182. McNeil Pharmaceutical, Orap: Prescribing Information, in: C. M. E. Krough (ed.), Compendium of Pharmaceuticals and Specialties (26th Ed.), Canadian Pharmaceutical Association, Toronto (1986), p. 546.
183. Lemmon Company, Orap (Pimozide): Prescribing Information, Sellersville, PA (1988).
184. M. H. Van Woert, D. Rosenbaum, and S. J. Enna, in: Gilles de la Tourette Syndrome, A. J. Friedhoff and T. N. Chase (eds.), Raven Press, New York (1982), pp. 369-375.
185. P. Seeman and T. Lee, Science, 188, 1217-1219 (1975).
186. H. Nyback, J. Schubert, and G. Sedvall, J. Pharm. Pharmacol., 22, 622-624 (1970).
187. N. E. Anden, S. G. Butcher, H. Corrodi, et al., Eur. J. Pharmacol., 11, 303-314 (1970).
188. L. E. Jonsson, Eur. J. Clin. Pharmacol., 4, 206-211 (1972).
189. M. Gowardman, B. Barrer, and R. A. Brown, N. Z. Med. J., 78, 487-491 (1973).
190. E. L. Denijs and J. L. T. M. Vereecken, Psychiatr. Neurol. Neurochir., 76, 47-59 (1973).
191. F. Kline, R. W. Burgoyne, and J. Yamamoto, Curr. Ther. Res., 21, 768-778 (1977).
192. J. Rotrosen, M. B. Wallach, B. Angrist, et al., Psychopharmacologia, 26, 185-194 (1972).
193. Yu. G. Bobkov, V. M. Vinogradov, V. F. Katkov, et al., Pharmacological Correction of Fatigue [in Russian], Meditsina, Moscow (1984), p. 208.
194. A. V. Smirnov, Pharmacological Means of Increasing the Working Capacity [in Russian], Military Medical Academy, Leningrad (1984), pp. 31-35.
195. Yu. G. Bobkov, V. M. Vinogradov, and A. V. Smirnov, Abstract of Papers. The 4th All-Union Symp. on Targeted Search for Physiologically Active Substances [in Russian], Riga (1981), p. 57.
196. V. M. Vinogradov and A. T. Grechko, Farmakol. Toksikol., No. 8, 5-9 (1982).
197. Yu. G. Bobkov and V. M. Vinogradov, Pharmacological Regulation of Fatigue Processes [in Russian], Meditsina, Moscow (1982), pp. 7-33.
198. Yu. G. Bobkov, Yu. I. Morozov, and A. I. Machula, Patol. Fiziol. Eksp. Terap., 2, 39-41 (1990).
199. A. V. Smirnov, Abstracts of Papers. The 1st All-Russia Congr. "Mankind and Drugs" (Moscow, 12-16 April, 1992) [in Russian], Moscow (1992), p. 419.
200. Yu. A. Aleksandrovskii, Organization of Psychic Aid and Therapy of Victims during and after Earthquakes [in Russian], Meditsina, Moscow (1989).
201. Yu. A. Aleksandrovskii, O. S. Lobastov, L. I. Spivak, and B. P. Shchukin, Psychogenesis under Extremal Conditions [in Russian], Meditsina, Moscow (1991).
202. A. A. Viru, Adrenal Cortex Function during Muscular Activity [in Russian], Meditsina, Moscow (1977).
203. A. A. Viru, Hormonal Mechanisms of Adaptation and Training [in Russian], Nauka, Leningrad (1981).
204. M. B. Plotnikov, A. S. Saratikov, T. M. Plotnikova, et al., Byull. Eksp. Biol. Med., 107(5), 583-585 (1989).
205. A. V. Tsibanev, Abstracts of Papers. The 1st All-Russia Congr. "Mankind and Drugs" (Moscow, 12-16 April, 1992) [in Russian], Moscow (1992), p. 421.
206. V. A. Kosolapov, V. A. Ostrovskii, and A. A. Spasov, Eksp. Klin. Farmakol., 59(6), 51-53 (1996).
207. V. A. Kosolapov, V. V. Drozd, V. A. Ostrovskii, and A. A. Spasov, in: Problems in Medicine of Disasters [in Russian], E. A. Vagner (ed.), Perm Gos. Med. Akad., Perm (1993), Part II, pp. 308-310.
208. A. A. Shipov, A. A. Spasov, V. A. Ostrovskii, and A. Ya. Pocheptsov, in: Problems in Medicine of Disasters [in Russian], E. A. Vagner (ed.), Perm Gos. Med. Akad., Perm (1993), Part II, pp. 260-264.
209. V. A. Ostrovskii, A. A. Shipov, A. A. Spasov, et al., Abstracts of Papers. The 1st All-Russia Congr. "Mankind and Drugs" (Moscow, 12-16 April, 1992) [in Russian], Moscow (1992), p. 421.
210. C. A. Rizzi, A. Prudentino, and E. Giraldo, Arzneimit. Forsch., 43(10), 1033-1041 (1993).
211. VIDAL Handbook. Drugs in Russia [in Russian], Astra-FarmServis, Moscow (1995), p. 1168.
212. T. Wada, Y. Inada, and T. Sanada, Eur. J. Pharmacol., 253(1-2), 27-34 (1994).
213. D. C. Norford, D. J. Meuten, J. M. Cullen, et al., Toxicol. Pathol., 21(5), 456-464 (1993).
214. Merck & Co., Inc., Prilosec (Omeprazole) Delayed Release Capsules: Prescribing Information, West Point, PA (1993).
215. M. H. Levin, R. A. Weinstein, J. L. Axelrod, et al., J. Am. Med. Acad., 249, 2929-2931 (1983).
216. P. F. Miskovitz and N. B. Javitt, Am. J. Trop. Med. Hyg., 29, 1356-1358 (1980).
217. A. Z. Prikhod'ko and E. I. Astashkin, Khim.-Farm. Zh., 26(3), 22-25 (1992).
218. I. R. Barilyak, Fiziol. Akt. Veshchestva, 6, 85-88 (1974).
219. I. R. Barilyak, Fiziol. Akt. Veshchestva, 8, 106-108 (1976).
220. T. Yamano, T. Noda, M. Shimizu, et al., Fundam. Appl. Toxicol., 25, 218-223 (1995).
221. K. S. Khera, Teratology, 7, 243-252 (1973).
222. J. A. Ruddick and K. S. Khera, Teratology, 12, 277-282 (1975).
223. S. D. Carter and J. W. Laskey, Toxicol. Lett., 11, 87-94 (1982).
224. S. D. Carter, R. A. Hess, and J. W. Laskey, Biol. Reprod., 37, 709-717 (1987).
225. T. V. Pastushenkov, Gigiena Sanit., 7, 83-85 (1983).
226. A. Janardhan, P. B. Sattur, and P. Sisodia, Bull. Environ. Contam. Toxicol., 33, 257-263 (1987).
227. R. J. Kavlock, N. Chernoff, L. E. Gray Jr., et al., Toxicol. Appl. Pharmacol., 62, 44-54 (1982).
228. A. M. Cummings, M. T. Ebron-McCoy, J. M. Rogers, et al., Fundam. Appl. Toxicol., 18, 288-293 (1992).
229. W. A. M. Duncan, Ph. G. Lemon, and A. K. Palmer, Cornell Vet., 64 (Suppl. 4), 5-6 (1974).
230. L. I. Bugaeva, A. A. Spasov, I. N. Yozhitsa, et al., Vestn. Volgograd. Med. Akad., No. 1, 23-27 (1996).
231. A. A. Spasov, L. I. Bugaeva, I. N. Yozhitsa, et al., Abstracts of Papers. The 3rd All-Russia Congr. "Mankind and Drugs" (Moscow, 16-20 April, 1996) [in Russian], Moscow (1996), p. 288.
232. A. A. Spasov, L. I. Bugaeva, I. N. Yozhitsa, et al., Abstracts of Papers. The 14th Int. Symp. Medical Chemistry (Maastricht, Netherlands, 8-12 September, 1996), N. Abstr. P-6.26.
233. R. E. Goncharova and A. V. Levina, Izv. Akad. Nauk BSSR, Ser. Biol. Nauk, No. 3, 44-48 (1980).
234. G. Seiler, Mutat. Res., 15(3), 237-236 (1972).
235. E. S. Selezneva, Z. P. Belousova, L. A. Gusak, et al., Khim.-Farm. Zh., 26(3), 59-62 (1992).
236. J. P. Seiler, Mutat. Res., 15, 273-276 (1972).
237. A. M. Sarrif, G. T. Arce, and D. F. Khahn, Mutat. Res., 321(1-2), 43-56 (1994).
238. J. P. Seiler, Mutat. Res., 40, 339-348 (1976).
239. J. A. Styles and A. Garner, Mutat. Res., 26, 177-187 (1974).
240. R. Barale, C. Scapoli, C. Meli, et al., Mutat. Res., 300(1), 15-28 (1993).
241. P. Van-Hummelen, A. Elhajouji, and M. Kirsch Volders, Mutagenesis, 10(1), 23-29 (1995).
242. S. B. Seredenin, Abstracts of Papers. The 3rd All-Union Conf. on Pharmacokinetics "Present-Day State and Prospects of Pharmacokinetics" (Moscow, 18-19 December, 1991) [in Russian], Moscow (1991), p. 49.
243. A. D. Durnev and S. B. Seredenin, Khim.-Farm. Zh., 24(2), 92-100 (1990).
244. G. J. Russell, J. H. Gill, and E. Lacey, Biochem. Pharmacol., 43(5), 1095-1100 (1992).
245. S. G. Whittaker and E. M. Faustman, Toxicol. Appl. Pharmacol., 113(1), 144-151 (1992).
246. A. Anumonye, T. Onibuwe-Johnson, and A. A. Marinho, W. Afr. J. Pharmacol. Drug Res., 2, 17-24 (1976).
247. C. S. Stier, A. Elizur, A. Yeret, et al., Curr. Ther. Res., 23, 632-641 (1978).
248. Pimozide for Tourette's Disorder, Med. Lett. Drugs Ther., 27, 3-4 (1985).
249. N. Pitsikas, A. Brambilla, and F. Borsini, Pharmacol. Biochem. Behav., 47(1), 95-99 (1994).
250. D. W. Bonhaus, D. N. Loury, L. B. Jakeman, et al., J. Pharmacol. Exp. Ther., 267(2), 961-970 (1993).
251. T. Kamato, H. Ito, T. Suzuki, et al., Jpn. J. Pharmacol., 67(3), 185-194 (1995).
252. P. G. McLean, I. M. Coupar, and P. Molenaar, Med. J. Aust., 159(11-12), 834 (1993).
253. J. C. Van Meel, W. Diederen, R. Haigh, et al., Eur. J. Pharmacol., 233(2-3), 295-297 (1993).
254. K. A. Wardle, E. S. Ellis, G. S. Baxter, et al., Br. J. Pharmacol., 112(3), 789-794 (1994).
255. S. L. Lacasa, Eur. J. Biochem., 146(2), 339 (1985).
256. S. L. Lacasa, J. Lipid Res., 27(4), 368 (1986).
257. J. J. Anderson, S. Kuo, T. N. Chase, and T. M. Engber, J. Pharmacol. Exp. Ther., 269(3), 1144-1151 (1994).
258. B. S. Sachais and J. E. Krause, Mol. Pharmacol., 46(1), 122-128 (1994).
259. L. Pradier, E. Habert Ortoli, L. Emile, et al., Mol. Pharmacol., 47(2), 314-321 (1995).
260. A. J. Sellers and M. L. Ashford, Br. J. Pharmacol., 113(3), 659-661 (1994).
261. S. P. Olesen, E. Munch, P. Moldt, and J. Drejer, Eur. J. Pharmacol., 251(1), 53-59 (1994).
262. K. Lee, I. C. Rowe, and M. L. Ashford, Eur. J. Pharmacol., 280(2), 215-219 (1995).
263. X. Xu, T. D. Tsai, J. Wang, et al., J. Pharmacol. Exp. Ther., 1(1), 362-369 (1994).
264. H. Satoh, T. Kobayashi, K. Higo, and A. Karasawa, Jpn. J. Pharmacol., 65(1), 45-50 (1994).
265. M. Kawakage, K. Sato, and A. Karasawa, Jpn. J. Pharmacol., 65(2), 163-166 (1994).
266. S. Shirakura, K. Higo, M. Takeda, and A. Karasawa, Jpn. J. Pharmacol., 65(2), 93-98 (1994).
267. K. Higo and A. Karasawa, Jpn. J. Pharmacol., 66(4), 471-479 (1994).
268. A. Welling, L. Lacinova, K. Donatin, et al., Pflugers Arch., 429(3), 400-411 (1995).